Medalist Diversified REIT, Inc. (MDRR)
NASDAQ: MDRR · Real-Time Price · USD
12.53
-0.42 (-3.24%)
At close: Mar 31, 2025, 4:00 PM
12.34
-0.19 (-1.52%)
After-hours: Mar 31, 2025, 4:05 PM EDT
Company Description
Medalist Diversified REIT Inc. is a Virginia-based real estate investment trust that specializes in acquiring, owning and managing commercial real estate in the Southeast region of the U.S. The Company’s strategy is to focus on commercial real estate which is expected to provide an attractive balance of risk and returns.
Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions.
Medalist Diversified REIT, Inc.
Country | United States |
Founded | 2015 |
IPO Date | Nov 28, 2018 |
Industry | REIT - Diversified |
Sector | Real Estate |
CEO | Francis Kavanaugh |
Contact Details
Address: Post Office Box 8436 Richmond, Virginia 23226 United States | |
Phone | (804) 338-7708 |
Website | medalistreit.com |
Stock Details
Ticker Symbol | MDRR |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001654595 |
CUSIP Number | 58403P105 |
ISIN Number | US58403P3038 |
SIC Code | 6798 |
Key Executives
Name | Position |
---|---|
Francis P. Kavanaugh | Chair of the Board, Chief Executive Officer, President, Secretary and Treasurer |
Charles Brent Winn Jr. | Chief Financial Officer |
Kevin Rich Egan C.A.I.A., C.F.A., C.P.A. | Director of Strategic Finance and Investor Relations |
Deron Colby Esq. | Counsel |
Erin Burke | Chief of Staff |
Benjamin Ore | Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 28, 2025 | SCHEDULE 13D | Filing |
Mar 24, 2025 | SCHEDULE 13D/A | Filing |
Mar 20, 2025 | SCHEDULE 13D/A | Filing |
Mar 18, 2025 | 8-K | Current Report |
Feb 27, 2025 | 10-K | Annual Report |
Feb 25, 2025 | 8-K | Current Report |
Feb 25, 2025 | 8-K/A | [Amend] Current report |
Feb 25, 2025 | SCHEDULE 13D/A | Filing |
Feb 6, 2025 | 8-K | Current Report |
Jan 29, 2025 | 8-K | Current Report |